BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for KYVERNA THERAPEUTICS, INC. · Biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · $60,000.00 income · posted Jul 17, 2026

Lobbying activity 1

Pharmacy

Outreach regarding cell therapies for autoimmune diseases.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem